Viewing Study NCT00962767

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 12:27 AM

Ignite Modification Date: 2025-12-25 @ 10:32 PM

Study NCT ID: NCT00962767

Status: COMPLETED

Last Update Posted: 2009-08-20

First Post: 2009-08-18

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module